The Recall Desk
HighFDA (Devices)·Z-2542-2025·Announced 2025-09-17

Urinary protein assay recalled over falsely depressed patient and calibration results

Atellica CH Urinary/Cerebrospinal Fluid Protein assay is recalled because of the potential for falsely depressed patient, quality control and calibration results, or delayed results. 11,811 units are affected.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Rubric level 3 covers risk-of-harm products where injury has not yet been reported; the notice states the assay can produce falsely depressed patient results and no injuries are reported.

Plain-English summary

The Atellica CH Urinary/Cerebrospinal Fluid Protein (UCFP) assay, material number 11097543, test code UCFP, UDI-DI 00630414279206, is being recalled across all lot numbers. The recall covers 11,811 units distributed in the United States and in many other countries.

The recall was issued because of the potential for falsely depressed patient, quality control and/or calibration results, or delayed results. The FDA classified the action as Class II.

Laboratories using this assay should follow the manufacturer's instructions, including any guidance on reviewing results already reported.

The recalled product

Product
Atellica CH Urinary/Cerebrospinal Fluid Protein (UCFP). Material Number: 11097543.
Affected units
11,811

Distribution

Distributed nationwide across the United States.

Same manufacturer · Siemens Healthcare Diagnostics, Inc.

See all →